| Authors: |
Gomez JL; Biobehavioral Imaging and Molecular Neuropsychopharmacology Section, National Institute on Drug Abuse Intramural Research Program, Baltimore, MD, USA., Ventriglia EN; Biobehavioral Imaging and Molecular Neuropsychopharmacology Section, National Institute on Drug Abuse Intramural Research Program, Baltimore, MD, USA., Frangos ZJ; Biobehavioral Imaging and Molecular Neuropsychopharmacology Section, National Institute on Drug Abuse Intramural Research Program, Baltimore, MD, USA., Sulima A; Drug Design and Synthesis Section, Molecular Targets and Medication Discovery Branch, National Institute on Drug Abuse Intramural Research Program, Baltimore, MD, USA., Robertson MJ; Department of Molecular and Cellular Physiology, Stanford University School of Medicine, Stanford, CA, USA.; Department of Structural Biology, Stanford University School of Medicine, Stanford, CA, USA., Sacco MD; Department of Molecular and Cellular Physiology, Stanford University School of Medicine, Stanford, CA, USA.; Department of Structural Biology, Stanford University School of Medicine, Stanford, CA, USA., Budinich RC; Biobehavioral Imaging and Molecular Neuropsychopharmacology Section, National Institute on Drug Abuse Intramural Research Program, Baltimore, MD, USA., Giosan IM; Department of Pharmacology, Physiology and Biophysics, Boston University Chobanian and Avedisian School of Medicine, Boston, MA, USA., Xie T; Department of Pharmacology, Physiology and Biophysics, Boston University Chobanian and Avedisian School of Medicine, Boston, MA, USA., Solis O; Biobehavioral Imaging and Molecular Neuropsychopharmacology Section, National Institute on Drug Abuse Intramural Research Program, Baltimore, MD, USA., Tischer AE; Biobehavioral Imaging and Molecular Neuropsychopharmacology Section, National Institute on Drug Abuse Intramural Research Program, Baltimore, MD, USA., Bossert JM; Neurobiology of Relapse Section, National Institute on Drug Abuse Intramural Research Program, Baltimore, MD, USA., Caldwell KE; Neurobiology of Relapse Section, National Institute on Drug Abuse Intramural Research Program, Baltimore, MD, USA., Bonbrest H; Neurobiology of Relapse Section, National Institute on Drug Abuse Intramural Research Program, Baltimore, MD, USA., Essmann A; Departament de Patologia i Terapèutica Experimental, Institut de Neurociències, Universitat de Barcelona, L'Hospitalet de Llobregat, Spain.; Neuropharmacology and Pain Group, Neuroscience Program, Bellvitge Institute for Biomedical Research (IDIBELL), L'Hospitalet de Llobregat, Spain., Garçon-Poca ZM; Departament de Patologia i Terapèutica Experimental, Institut de Neurociències, Universitat de Barcelona, L'Hospitalet de Llobregat, Spain.; Neuropharmacology and Pain Group, Neuroscience Program, Bellvitge Institute for Biomedical Research (IDIBELL), L'Hospitalet de Llobregat, Spain., Choi S; Behavioral Neuroscience Research Branch, National Institute on Drug Abuse Intramural Research Program, Baltimore, MD, USA., Noya MR; Behavioral Neuroscience Research Branch, National Institute on Drug Abuse Intramural Research Program, Baltimore, MD, USA., Limiac F; Behavioral Neuroscience Research Branch, National Institute on Drug Abuse Intramural Research Program, Baltimore, MD, USA., Arce A; Behavioral Neuroscience Research Branch, National Institute on Drug Abuse Intramural Research Program, Baltimore, MD, USA., Glatfelter GC; Designer Drug Research Unit, National Institute on Drug Abuse Intramural Research Program, Baltimore, MD, USA., Robinson M; Computational Chemistry and Molecular Biophysics Section, National Institute on Drug Abuse Intramural Research Program, Baltimore, MD, USA., Chen L; Computational Chemistry and Molecular Biophysics Section, National Institute on Drug Abuse Intramural Research Program, Baltimore, MD, USA., Mullarkey AA; Department of Molecular and Cellular Physiology, Stanford University School of Medicine, Stanford, CA, USA., Brademan DR; Department of Molecular and Cellular Physiology, Stanford University School of Medicine, Stanford, CA, USA., Enten G; Integrative Neurobiology Section, National Institute on Drug Abuse Intramural Research Program, Baltimore, MD, USA., Dunne W; Biobehavioral Imaging and Molecular Neuropsychopharmacology Section, National Institute on Drug Abuse Intramural Research Program, Baltimore, MD, USA., Quiroz C; Integrative Neurobiology Section, National Institute on Drug Abuse Intramural Research Program, Baltimore, MD, USA., Schoenborn I; Biobehavioral Imaging and Molecular Neuropsychopharmacology Section, National Institute on Drug Abuse Intramural Research Program, Baltimore, MD, USA., Lee CB; Johns Hopkins Drug Discovery, Johns Hopkins School of Medicine, Baltimore, MD, USA.; Department of Neurology, Johns Hopkins School of Medicine, Baltimore, MD, USA., Rais R; Johns Hopkins Drug Discovery, Johns Hopkins School of Medicine, Baltimore, MD, USA.; Department of Neurology, Johns Hopkins School of Medicine, Baltimore, MD, USA., Holt DP; Department of Radiology, Johns Hopkins School of Medicine, Baltimore, MD, USA., Dannals RF; Department of Radiology, Johns Hopkins School of Medicine, Baltimore, MD, USA., Shi L; Computational Chemistry and Molecular Biophysics Section, National Institute on Drug Abuse Intramural Research Program, Baltimore, MD, USA., Hüttenhain R; Department of Molecular and Cellular Physiology, Stanford University School of Medicine, Stanford, CA, USA., Ferré S; Integrative Neurobiology Section, National Institute on Drug Abuse Intramural Research Program, Baltimore, MD, USA., Kiyatkin E; Behavioral Neuroscience Research Branch, National Institute on Drug Abuse Intramural Research Program, Baltimore, MD, USA., Bonaventura J; Departament de Patologia i Terapèutica Experimental, Institut de Neurociències, Universitat de Barcelona, L'Hospitalet de Llobregat, Spain.; Neuropharmacology and Pain Group, Neuroscience Program, Bellvitge Institute for Biomedical Research (IDIBELL), L'Hospitalet de Llobregat, Spain., Shaham Y; Neurobiology of Relapse Section, National Institute on Drug Abuse Intramural Research Program, Baltimore, MD, USA., Zachariou V; Department of Pharmacology, Physiology and Biophysics, Boston University Chobanian and Avedisian School of Medicine, Boston, MA, USA., Baumann MH; Designer Drug Research Unit, National Institute on Drug Abuse Intramural Research Program, Baltimore, MD, USA., Skiniotis G; Department of Molecular and Cellular Physiology, Stanford University School of Medicine, Stanford, CA, USA. georgios.skiniotis@stjude.org.; Department of Structural Biology, Stanford University School of Medicine, Stanford, CA, USA. georgios.skiniotis@stjude.org.; Department of Structural Biology, St Jude Children's Research Hospital, Memphis, TN, USA. georgios.skiniotis@stjude.org.; Center of Excellence for Structural Cell Biology, St Jude Children's Research Hospital, Memphis, TN, USA. georgios.skiniotis@stjude.org., Rice KC; Drug Design and Synthesis Section, Molecular Targets and Medication Discovery Branch, National Institute on Drug Abuse Intramural Research Program, Baltimore, MD, USA. kennerr@nida.nih.gov., Michaelides M; Biobehavioral Imaging and Molecular Neuropsychopharmacology Section, National Institute on Drug Abuse Intramural Research Program, Baltimore, MD, USA. mike.michaelides@nih.gov. |
